Selected article for: "case control and control case"
Title: 2018 ACVIM Forum Research Abstract Program: Seattle, Washington, June 14 - 15, 2018
  • Document date: 2018_10_25
    • ID: 60ceejq1_478
    Snippet: This study did not identify a difference in clinical severity improvement, duration of hospitalization, or mortality when comparing HIP and placebo dogs. Future studies evaluating HIP dose, and timing of HIP administration relative to disease onset, are needed to better determine the clinical benefit of this product. This study was a retrospective prevalence case-control study. One This study demonstrates that Borrelia C6 seroreactivity in dogs w.....
    Document: This study did not identify a difference in clinical severity improvement, duration of hospitalization, or mortality when comparing HIP and placebo dogs. Future studies evaluating HIP dose, and timing of HIP administration relative to disease onset, are needed to better determine the clinical benefit of this product. This study was a retrospective prevalence case-control study. One This study demonstrates that Borrelia C6 seroreactivity in dogs with PLN is associated with a clinicopathologically distinct syndrome when compared with other types of PLN. Early recognition of this syndrome based on clinical findings has the potential to improve outcomes through specific aggressive and early treatment. We therefore aimed to evaluate the clinical need for antibiotics in a common condition where it is suspected primary-care veterinarians overuse antibiotics. We chose to study haemorrhagic diarrhoea in dogs, where two antibiotics are often administered as standard. Both amoxicillin-clavulanic acid and metronidazole are typically prescribed to severe cases of haemorrhagic diarrhoea, but there is no evidence that this is beneficial to the patient.

    Search related documents:
    Co phrase search for related documents
    • antibiotic clinical need and clinical need: 1, 2, 3, 4
    • case control and clinical benefit: 1, 2, 3
    • case control and clinical finding: 1, 2, 3, 4
    • case control and clinical need: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • case control and common condition: 1, 2
    • case control and early recognition: 1, 2, 3, 4, 5, 6
    • case control and future study: 1, 2, 3, 4, 5
    • clinical benefit and common condition: 1, 2
    • clinical benefit and early recognition: 1
    • clinical benefit and future study: 1, 2, 3, 4
    • clinical finding and common condition: 1
    • clinical finding and early aggressive treatment: 1
    • clinical finding and future study: 1
    • clinical need and common condition: 1
    • clinical need and early aggressive treatment: 1, 2
    • clinical need and early recognition: 1, 2
    • clinical need and future study: 1, 2, 3, 4, 5, 6, 7, 8
    • common condition and early recognition: 1, 2
    • common condition and future study: 1, 2